Predictors of Viremia in Postpartum Women on Antiretroviral Therapy
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/43004 |
Resumo: | Acesso aberto em 26/08/2020 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898779/ |
id |
CRUZ_951ba0ee56a108c5b9608e66c6f2a79b |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/43004 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Hoffman, Risa M.Warshaw, Meredith G.Amico, K. RivetPilotto, JoséMasheto, GaerolweAchalapong, JullapongMachado, ElizabethChokephaibulkit, KulkanyaDuarte, GeraldoJoão, EsauGraham, Kathleen K.Knapp, Katherine M.Stek, Alice M.Scott, Gwendolyn B.Coletti, AnneLoftis, Amy J.Chakhtoura, NahidaCurrier, Judith S.PROMISE 1077HS Team2020-08-26T20:01:31Z2020-08-26T20:01:31Z2020HOFFMAN, Risa M. et al. Predictors of Viremia in Postpartum Women on Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes, v. 83, n. 1, p. 72-80, Jan. 2020.1525-4135https://www.arca.fiocruz.br/handle/icict/4300410.1097/QAI.0000000000002228Acesso aberto em 26/08/2020 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898779/Division of Infectious Diseases. David Geffen School of Medicine. University of California. Los Angeles, Los Angeles, CA, USA.Center for Biostatistics in AIDS Research. Harvard T.H. Chan School of Public Health. Boston, MA, USA.Health Behavior & Health Education. School of Public Health. University of Michigan. Ann Arbor, MI, USA.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil.Botswana Harvard AIDS Institute Partnership. Gaborone, Botswana.Chiang Rai Prachanukroh Hospital. Chiang Rai, Thailand.Universidade Federal do Rio de Janeiro. Instituto de Puericultura e Pediatria Martagão. Rio de Janeiro, RJ, Brasil.Faculty of Medicine Siriraj Hospital. Mahidol University. Bangkok, Thailand.Universidade de São Paulo. Escola de Medicina de Ribeirão Preto. Ribeirão Preto, SP, Brasil.Hospital Federal dos Servidores do Estado. Departamento de Doenças Infecciosas. Rio de Janeiro, RJ, Brasil.Children’s Diagnostic and Treatment Center. Fort Lauderdale, FL, USA.Infectious Diseases Department. St Jude Children’s Research Hospital. Memphis, TN, USA.Department of Obstetrics and Gynecology. School of Medicine. University of Southern California. Los Angeles, CA, USA.School of Medicine. University of Miami Miller. Miami, FL, USA.FHI 360. Durham, NC, USA.Institute for Global Health and Infectious Diseases. University of North Carolina. Chapel Hill, NC, USA.Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH. Bethesda, MD, USA.Division of Infectious Diseases. David Geffen School of Medicine. University of California Los Angeles, Los Angeles, CA, USA.PROMISE 1077HS TeamBackground: HIV-infected, postpartum women on antiretroviral therapy (ART) have high rates of viremia. We examined predictors of postpartum viremia in the PROMISE study. Methods: Women with pre-ART CD4+ T-cell counts $400 cells/mm3 who started ART during pregnancy were randomized postpartum to continue ART (CTART) or discontinue ART (DCART). Viral load and self-reported adherence were collected every 12 weeks, up to 144 weeks. Women in DCART reinitiated therapy when clinically indicated. Viremia was defined as 2 consecutive viral loads .1000 copies/mL after 24 weeks on ART. Adherence was dichotomized as missing versus not missing ART doses in the past 4 weeks. Predictors of viremia were examined using Cox proportional hazards regression with adherence as a time-varying covariate. Results: Among 802 women in the CTART arm, median age at entry was 27 years and median CD4+ T-cell count 696 cells/mm3. Of 175 women in CTART with viremia (22%), 141 had resistance data, and 12% had resistance to their current regimen. There was an estimated 0.12 probability of viremia by week 48 and 0.25 by week 144. Predictors of viremia included missed ART doses within the past 4 weeks, younger age, shorter duration of pre-entry ART, and being from the South American/Caribbean region. Of 137 women in DCART who reinitiated therapy, probability of viremia was similar to CTART (0.24 by week 96; 0.27 by week 144). Conclusions: Rates of postpartum viremia are high and viremia is more likely in younger postpartum women who start ART later in pregnancy. Interventions should target these higher-risk women.engWolters Kluwer Health, Inc.ViremiaTerapia antirretroviralMulheres pós-partoViremiaAntiretroviral TherapyPostpartum WomenPredictors of Viremia in Postpartum Women on Antiretroviral Therapyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/43004/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALJosePilotto_etal_IOC_2020.pdfJosePilotto_etal_IOC_2020.pdfapplication/pdf304586https://www.arca.fiocruz.br/bitstream/icict/43004/2/JosePilotto_etal_IOC_2020.pdf2194d79988cce538dbf13fa1338e47d4MD52TEXTJosePilotto_etal_IOC_2020.pdf.txtJosePilotto_etal_IOC_2020.pdf.txtExtracted texttext/plain43915https://www.arca.fiocruz.br/bitstream/icict/43004/3/JosePilotto_etal_IOC_2020.pdf.txtfeace77a1d77110dd06fbafd8bead59cMD53icict/430042020-12-01 22:18:14.662oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352020-12-02T01:18:14Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Predictors of Viremia in Postpartum Women on Antiretroviral Therapy |
title |
Predictors of Viremia in Postpartum Women on Antiretroviral Therapy |
spellingShingle |
Predictors of Viremia in Postpartum Women on Antiretroviral Therapy Hoffman, Risa M. Viremia Terapia antirretroviral Mulheres pós-parto Viremia Antiretroviral Therapy Postpartum Women |
title_short |
Predictors of Viremia in Postpartum Women on Antiretroviral Therapy |
title_full |
Predictors of Viremia in Postpartum Women on Antiretroviral Therapy |
title_fullStr |
Predictors of Viremia in Postpartum Women on Antiretroviral Therapy |
title_full_unstemmed |
Predictors of Viremia in Postpartum Women on Antiretroviral Therapy |
title_sort |
Predictors of Viremia in Postpartum Women on Antiretroviral Therapy |
author |
Hoffman, Risa M. |
author_facet |
Hoffman, Risa M. Warshaw, Meredith G. Amico, K. Rivet Pilotto, José Masheto, Gaerolwe Achalapong, Jullapong Machado, Elizabeth Chokephaibulkit, Kulkanya Duarte, Geraldo João, Esau Graham, Kathleen K. Knapp, Katherine M. Stek, Alice M. Scott, Gwendolyn B. Coletti, Anne Loftis, Amy J. Chakhtoura, Nahida Currier, Judith S. PROMISE 1077HS Team |
author_role |
author |
author2 |
Warshaw, Meredith G. Amico, K. Rivet Pilotto, José Masheto, Gaerolwe Achalapong, Jullapong Machado, Elizabeth Chokephaibulkit, Kulkanya Duarte, Geraldo João, Esau Graham, Kathleen K. Knapp, Katherine M. Stek, Alice M. Scott, Gwendolyn B. Coletti, Anne Loftis, Amy J. Chakhtoura, Nahida Currier, Judith S. PROMISE 1077HS Team |
author2_role |
author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Hoffman, Risa M. Warshaw, Meredith G. Amico, K. Rivet Pilotto, José Masheto, Gaerolwe Achalapong, Jullapong Machado, Elizabeth Chokephaibulkit, Kulkanya Duarte, Geraldo João, Esau Graham, Kathleen K. Knapp, Katherine M. Stek, Alice M. Scott, Gwendolyn B. Coletti, Anne Loftis, Amy J. Chakhtoura, Nahida Currier, Judith S. PROMISE 1077HS Team |
dc.subject.other.pt_BR.fl_str_mv |
Viremia Terapia antirretroviral Mulheres pós-parto |
topic |
Viremia Terapia antirretroviral Mulheres pós-parto Viremia Antiretroviral Therapy Postpartum Women |
dc.subject.en.pt_BR.fl_str_mv |
Viremia Antiretroviral Therapy Postpartum Women |
description |
Acesso aberto em 26/08/2020 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898779/ |
publishDate |
2020 |
dc.date.accessioned.fl_str_mv |
2020-08-26T20:01:31Z |
dc.date.available.fl_str_mv |
2020-08-26T20:01:31Z |
dc.date.issued.fl_str_mv |
2020 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
HOFFMAN, Risa M. et al. Predictors of Viremia in Postpartum Women on Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes, v. 83, n. 1, p. 72-80, Jan. 2020. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/43004 |
dc.identifier.issn.pt_BR.fl_str_mv |
1525-4135 |
dc.identifier.doi.none.fl_str_mv |
10.1097/QAI.0000000000002228 |
identifier_str_mv |
HOFFMAN, Risa M. et al. Predictors of Viremia in Postpartum Women on Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes, v. 83, n. 1, p. 72-80, Jan. 2020. 1525-4135 10.1097/QAI.0000000000002228 |
url |
https://www.arca.fiocruz.br/handle/icict/43004 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Wolters Kluwer Health, Inc. |
publisher.none.fl_str_mv |
Wolters Kluwer Health, Inc. |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/43004/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/43004/2/JosePilotto_etal_IOC_2020.pdf https://www.arca.fiocruz.br/bitstream/icict/43004/3/JosePilotto_etal_IOC_2020.pdf.txt |
bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 2194d79988cce538dbf13fa1338e47d4 feace77a1d77110dd06fbafd8bead59c |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009083513438208 |